TCL Archive Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials May 28, 1999
TCL Archive In brief: Cancer Investment “Drop In The Bucket,” OMB Is The “Second Greatest Kill,” Pepper Says August 10, 1979
TCL Archive NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution November 1, 1974
TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012
